{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:19:44Z","timestamp":1791933584087,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Plasmodium<\/jats:italic>\n              <jats:italic>falciparum<\/jats:italic> malaria remains a significant public health concern in Tanzania, particularly among children under 5\u00a0years of age. The emergence and spread of partial artemisinin resistance in East Africa add to this concern. Specific mutations in the <jats:italic>P.<\/jats:italic>\n              <jats:italic>falciparum<\/jats:italic>\n              <jats:italic>kelch-13<\/jats:italic> (<jats:italic>Pfk13<\/jats:italic>) and <jats:italic>multidrug drug resistance 1<\/jats:italic> (<jats:italic>Pfmdr1<\/jats:italic>) genes are associated with artemisinin resistance and lumefantrine tolerance, respectively. The emergence of antimalarial drug resistance may be associated with unstable transmission in sub-Saharan Africa (SSA). Time-trends of <jats:italic>Pfk13<\/jats:italic> and <jats:italic>Pfmdr1<\/jats:italic> mutations as well as the multiplicity of infection (MOI) as a proxy for transmission intensity were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Between 2016 and 2022, 173 <jats:italic>P. falciparum<\/jats:italic> PCR-positive samples were collected from febrile inpatient and outpatient children aged 3\u00a0months to 18\u00a0years at selected health facilities in Mwanza, Tanzania. <jats:italic>Pfk13<\/jats:italic> and <jats:italic>Pfmdr1<\/jats:italic> were amplified by PCR and Sanger-sequenced. Polymorphic <jats:italic>Pfmsp1<\/jats:italic> and <jats:italic>Pfmsp2<\/jats:italic> allelic markers were genotyped by nested PCR in 168 samples to assess MOI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 143 samples successfully sequenced for <jats:italic>Pfk13<\/jats:italic>, 7.0% (10\/143) exhibited non-synonymous mutations including the WHO-validated artemisinin resistance marker R561H in 1.4% (2 patients, 2022). As for <jats:italic>Pfmdr1<\/jats:italic>, the wild-type N86 allele was observed in 100% (97\/97) of isolates, and about half (55\/97) carried the wild-type Y184 allele. The mean multiplicity of infection (MOI) was 1.5, and did not change significantly over time. Single-genotype and polyclonal infections were observed in 59.3% (80\/135), and 40.7% (55\/135) respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study from Mwanza, Tanzania demonstrates the presence of a validated artemisinin resistance marker <jats:italic>Pfk13<\/jats:italic> R561H in 2022 and suggests increased lumefantrine tolerance. MOI as a proxy marker of endemicity was low and stable over the six years of observation. The detection of these resistance markers reinforces the need for continuous genetic surveillance to sustain the efficacy of antimalarial therapies in paediatric patients.  <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05447-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:51:45Z","timestamp":1751377905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016\u20132022"],"prefix":"10.1186","volume":"24","author":[{"given":"Aveline","family":"Assey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scialabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mgella","family":"Zinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Koliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welmoed","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Minja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Groendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Plett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M.","family":"Mirambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema","family":"Kayange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Mshana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5447_CR1","first-page":"2024","volume-title":"World malaria report addressing inequity in the global malaria response","author":"WHO","year":"2024","unstructured":"WHO. World malaria report addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. p. 2024."},{"key":"5447_CR2","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","volume":"24","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal PJ, Asua V, Bailey JA, Conrad MD, Ishengoma DS, Kamya MR, et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis. 2024;24:e591\u2013600.","journal-title":"Lancet Infect Dis"},{"key":"5447_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","volume":"24","author":"DS Ishengoma","year":"2024","unstructured":"Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, et al. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect Dis. 2024;24:1225\u201333.","journal-title":"Lancet Infect Dis"},{"key":"5447_CR4","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"5447_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm RW, Imwong M, Chau NH, Hoa NT, Thuy-Nhien NT, Thanh NV, et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect Dis. 2019;19:952\u201361.","journal-title":"Lancet Infect Dis"},{"key":"5447_CR6","unstructured":"WHO. Malaria: Artemisinin partial resistance. Geneva: World Health Organization; 2025 [cited 2025 Jan 6]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/artemisinin-resistance"},{"key":"5447_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S1473-3099(12)70241-4","volume":"12","author":"AO Talisuna","year":"2012","unstructured":"Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, et al. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis. 2012;12:888\u201396.","journal-title":"Lancet Infect Dis"},{"key":"5447_CR8","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","volume":"10","author":"GM Bwire","year":"2020","unstructured":"Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AA. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.","journal-title":"Sci Rep"},{"key":"5447_CR9","doi-asserted-by":"crossref","unstructured":"Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, et al. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. medRxiv. (preprint), 2023.","DOI":"10.1101\/2023.11.07.23298207"},{"key":"5447_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12936-020-03250-4","volume":"19","author":"SG Thawer","year":"2020","unstructured":"Thawer SG, Chacky F, Runge M, Reaves E, Mandike R, Lazaro S, et al. Sub-national stratification of malaria risk in mainland Tanzania: a simplified assembly of survey and routine data. Malar J. 2020;19:177.","journal-title":"Malar J"},{"key":"5447_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722\u201332.","journal-title":"N Engl J Med"},{"key":"5447_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12936-020-03330-5","volume":"19","author":"R Noviyanti","year":"2020","unstructured":"Noviyanti R, Miotto O, Barry A, Marfurt J, Siegel S, Thuy-Nhien N, et al. Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region. Malar J. 2020;19:271.","journal-title":"Malar J"},{"key":"5447_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00188-22","volume":"66","author":"EM Sarah-Matio","year":"2022","unstructured":"Sarah-Matio EM, Guillochon E, Nsango SE, Abate L, Ngou CM, Bouopda GA, et al. Genetic diversity of Plasmodium falciparum and distribution of antimalarial drug resistance mutations in symptomatic and asymptomatic infections. Antimicrob Agents Chemother. 2022;66: e0018822.","journal-title":"Antimicrob Agents Chemother"},{"key":"5447_CR14","doi-asserted-by":"publisher","first-page":"RP90888","DOI":"10.7554\/eLife.90888","volume":"12","author":"Q He","year":"2024","unstructured":"He Q, Chaillet JK, Labbe F. Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance. Elife. 2024;12:RP90888.","journal-title":"Elife"},{"key":"5447_CR15","unstructured":"National Bureau of Statistics. National Climate Change Statistics Report, 2019, Tanzania Mainland. Dodoma, Tanzania; 2020."},{"key":"5447_CR16","unstructured":"WHO. Guidelines for malaria [Internet]. Geneva: World Health Organization; 2022 [cited 2025 Mar 13]. Available from: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria"},{"key":"5447_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12936-021-03595-4","volume":"20","author":"P Koliopoulos","year":"2021","unstructured":"Koliopoulos P, Kayange NM, Daniel T, Huth F, Gr\u00f6ndahl B, Medina-Monta\u00f1o GC, et al. Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards. Malar J. 2021;20:66.","journal-title":"Malar J"},{"key":"5447_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1385\/1-59259-271-6:103","volume":"72","author":"G Snounou","year":"2002","unstructured":"Snounou G. Genotyping of Plasmodium spp. nested PCR. Malar Methods Protoc. 2002;72:103\u201316.","journal-title":"Malar Methods Protoc."},{"key":"5447_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13071-018-2895-4","volume":"11","author":"AF Some","year":"2018","unstructured":"Some AF, Bazie T, Zongo I, Yerbanga RS, Nikiema F, Neya C, et al. Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso. Parasit Vectors. 2018;11:323.","journal-title":"Parasit Vectors"},{"key":"5447_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-2875-2-12","volume":"2","author":"A Aubouy","year":"2003","unstructured":"Aubouy A, Migot-Nabias F, Deloron P. Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Malar J. 2003;2:12.","journal-title":"Malar J"},{"key":"5447_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12936-020-03563-4","volume":"20","author":"MA Oboh","year":"2021","unstructured":"Oboh MA, Ndiaye T, Diongue K, Ndiaye YD, Sy M, Deme AB, et al. Allelic diversity of MSP1 and MSP2 repeat loci correlate with levels of malaria endemicity in Senegal and Nigerian populations. Malar J. 2021;20:38.","journal-title":"Malar J"},{"key":"5447_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5447_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1179\/2047773214Y.0000000158","volume":"108","author":"J Li","year":"2014","unstructured":"Li J, Chen J, Xie D, Monte-Nguba SM, Eyi JU, Matesa RA, et al. High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island. Equatorial Guinea Pathog Glob Health. 2014;108:339\u201343.","journal-title":"Equatorial Guinea Pathog Glob Health"},{"key":"5447_CR24","unstructured":"StataCorp. Stata Statistical Software: Release 15. College Station (TX): StataCorp LLC; 2017."},{"key":"5447_CR25","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2023. Available from: https:\/\/www.R-project.org\/"},{"key":"5447_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1475-2875-9-131","volume":"9","author":"JM Kang","year":"2010","unstructured":"Kang JM, Moon SU, Kim JY, Cho SH, Lin K, Sohn WM, et al. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Malar J. 2010;9:131.","journal-title":"Malar J"},{"key":"5447_CR27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3201\/eid2507.181614","volume":"25","author":"B Yakubu","year":"2019","unstructured":"Yakubu B, Longdet IY, Jen TH, Davou DT, Obishakin E. High-complexity Plasmodium falciparum infections, North Central Nigeria, 2015\u20132018. Emerg Infect Dis. 2019;25:1330\u20138.","journal-title":"Emerg Infect Dis"},{"key":"5447_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-024-04896-0","volume":"23","author":"C Bakari","year":"2024","unstructured":"Bakari C, Mandara CI, Madebe RA, Seth MD, Ngasala B, Kamugisha E, et al. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021. Malar J. 2024;23:71.","journal-title":"Malar J"},{"key":"5447_CR29","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602\u20138.","journal-title":"Nat Med"},{"key":"5447_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264548","volume":"17","author":"FV Ajogbasile","year":"2022","unstructured":"Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, et al. Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. PLoS ONE. 2022;17: e0264548.","journal-title":"PLoS ONE"},{"key":"5447_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1128\/AAC.01346-15","volume":"60","author":"A Boussaroque","year":"2015","unstructured":"Boussaroque A, Fall B, Madamet M, Camara C, Benoit N, Fall M, et al. Emergence of mutations in the K13 propeller gene of Plasmodium falciparum isolates from Dakar, Senegal, in 2013\u20132014. Antimicrob Agents Chemother. 2015;60:624\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"5447_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","volume":"16","author":"L Ndwiga","year":"2021","unstructured":"Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5447_CR33","unstructured":"WHO, Global Malaria Programme. Artemisinin and artemisinin-based combination therapy resistance [Internet]. Geneva: World Health Organization; 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/artemisinin-and-act-resistance"},{"key":"5447_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/infdis\/jiae475","volume":"231","author":"N Wernsman Young","year":"2025","unstructured":"Wernsman Young N, Gashema P, Giesbrecht D, Munyaneza T, Maisha F, et al. High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing. J Infect Dis. 2025;231:269\u201380.","journal-title":"J Infect Dis"},{"key":"5447_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100476","volume":"13","author":"RK Kakulu","year":"2024","unstructured":"Kakulu RK, Msuya MM, Makora SH, Lucas AM, Kapinga JV, Mwangoka NK, et al. Characterization of population connectivity for enhanced cross-border surveillance of yellow fever at Mutukula and Namanga borders in Tanzania. IJID Reg. 2024;13: 100476.","journal-title":"IJID Reg"},{"key":"5447_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/17441692.2016.1178318","volume":"13","author":"KD Deane","year":"2018","unstructured":"Deane KD, Samwell Ngalya P, Boniface L, Bulugu G, Urassa M. Exploring the relationship between population mobility and HIV risk: evidence from Tanzania. Glob Public Health. 2018;13:173\u201388.","journal-title":"Glob Public Health"},{"key":"5447_CR37","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/infdis\/jis747","volume":"207","author":"M Malmberg","year":"2013","unstructured":"Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;207:842\u20137.","journal-title":"J Infect Dis"},{"key":"5447_CR38","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnadig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"5447_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000999","volume":"3","author":"LC Okell","year":"2018","unstructured":"Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa. BMJ Glob Health. 2018;3: e000999.","journal-title":"BMJ Glob Health"},{"key":"5447_CR40","doi-asserted-by":"publisher","first-page":"5089143","DOI":"10.1155\/2022\/5089143","volume":"2022","author":"KJ Marwa","year":"2022","unstructured":"Marwa KJ, Lyimo E, Konje ET, Kapesa A, Kamugisha E, Swedberg G. Plasmodium falciparum merozoite surface proteins polymorphisms and treatment outcomes among patients with uncomplicated malaria in Mwanza, Tanzania. J Trop Med. 2022;2022:5089143.","journal-title":"J Trop Med"},{"key":"5447_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13071-020-04302-z","volume":"13","author":"P Sondo","year":"2020","unstructured":"Sondo P, Derra K, Rouamba T, Nakanabo Diallo S, Taconet P, Kazienga A, et al. Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso. Parasit Vectors. 2020;13:427.","journal-title":"Parasit Vectors"},{"key":"5447_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12936-025-05361-2","volume":"24","author":"R Budodo","year":"2025","unstructured":"Budodo R, Mandai SS, Bakari C, Seth MD, Francis F, Chacha GA, et al. Performance of rapid diagnostic tests, microscopy, and qPCR for detection of Plasmodium parasites among community members with or without symptoms of malaria in villages located in North-western Tanzania. Malar J. 2025;24:115.","journal-title":"Malar J"},{"key":"5447_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12936-024-04925-y","volume":"23","author":"A Mwesigwa","year":"2024","unstructured":"Mwesigwa A, Ocan M, Musinguzi B, Nante RW, Nankabirwa JI, Kiwuwa SM, et al. Plasmodium falciparum genetic diversity and multiplicity of infection based on msp-1, msp-2, glurp and microsatellite genetic markers in sub-Saharan Africa: a systematic review and meta-analysis. Malar J. 2024;23:97.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:51:48Z","timestamp":1751377908000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05447-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, and the participants\u2019 parents consented to participate in this study. Ethical approval was granted by the CUHAS\/BMC Research Ethics and Review Committee with certificate number CREC\/674\/2023 and was also obtained from the National Institute of Medical Research (NIMR) of Tanzania (NIMR\/HQ\/R.8a\/Vol. IX\/2641), including the Data and Material Transfer Agreements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}